Added to YB: 2026-06-01
Pitch date: 2026-05-28
HIGH.DE [bullish]
Cantourage Group SE
Author Info
No bio for this author
Company Info
Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products.
Market Cap
EUR 81.6M
Pitch Price
N/A
Price Target
9.60
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
20.84
Sector
Pharmaceuticals
Category
growth
Cantourage Group SE (XETRA: HIGH) The Quiet German Cannabis Compounder Nobody Is Watching?
HIGH.DE: Profitable, founder-led (66% insider) asset-light medical cannabis aggregator, pan-European. 2025 rev €92.8M (+82%), EBITDA €5.7M. HGB goodwill amortization hides ~€5M true earnings. 2028 normalized EPS €0.60 at 16x Fair-PE = €9.60 fair value, ~16% annual upside +options. Mispriced on German MedCanG telemedicine/mail-order tightening fear, sector trauma, micro-cap illiquidity. Catalysts: new markets (Spain/France/Italy), IFRS switch, recreational liberalization.
Read full article (9 min)